Effectiveness of management protocol for insulin balls in diabetics: a scoping review

Nagase T, Katsura Y, Iwaki Y, Kemoto K, Sekine H, Miwa K, et al. The insulin ball. Lancet. 2009;373(9658):184. https://doi.org/10.1016/S0140-6736(09)60041-6. Nagase T, Iwaya K, Iwaki Y, Kotake F, Uchida R, Ohi T, et al. Insulin-derived amyloidosis and poor glycemic control: a case series. Am J Med. 2014;127(5):450–4. https://doi.org/10.1016/j.amjmed.2013.10.029. International Diabetes Federation Diabetes Atlas. Diabetes around the world in 2021. (2021). https://diabetesatlas.org/. Accessed 30 Dec 2022 Nagase T, Iwaya K, Zako T, Odaka T, Kogure K, Nemoto Y, et al. Clinical and MRI characteristics and follow-up studies of insulin-derived amyloidosis. Amyloid. 2019;26(sup1):156–7. https://doi.org/10.1080/13506129.2019.1582517. Samlaska C, Reber S, Murry T. Insulin-derived amyloidosis: the insulin ball, amyloidoma. JAAD Case Rep. 2020;6(4):351–3. https://doi.org/10.1016/j.jdcr.2020.02.011. American Diabetes Association. Insulin Routines. (2022). https://www.diabetes.org/healthy-living/medication-treatments/insulin-other-injectables/insulin-routines. Accessed 30 Dec 2022 Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. https://doi.org/10.7326/M-18-0850. Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6. https://doi.org/10.1097/XEB.0000000000000050. Sato K, Ohtani N, Nakagawa M. [Prevention of subcutaneous induration in patients under insulin self-injection therapy: Introduction of hand-site rotation.] Insurin jiko chusha kanja no hifu kouketsu yobou handosaitorōtēshon no dounyu. [The collection of papers of The Japan Society of Nursing: Chronic Nursing] Nihon kango gakkai ronbunshu: manseiki kango. 2019;49:171–4 (in Japanese). Tanaka K, Shimizu M, Kikuchi M, Katou Y, Tanaka K, Nakazato R, et al. The usefulness of subcutaneous tissue ultrasonography in the insulin self-injection guidance by nurses. J Japan Diabetes Soc. 2019;62(2):76–83 (in Japanese). Matsumoto K. [Induration disrupts insulin therapy: Insulin-derived amyloidosis (insulin balls) and diabetes education by diabetes care team] Kouketsu ha insurin chiryou no jama wo suru insurin yurai amiroidōshisu (insurin bōru) to tounyoubyou iryou tīmu ni yoru ryouyou shidou. Japanese J Pharma Diabetes. 2020;9(2):251–5 (in Japanese). Hoshino Y, Takahashi M, Murakami N, Suzuki M, Endou M, Abe U. [From DM Staff/From the nurse station/The importance of guidance for insulin self-injection sites: The use of a training sheet for patients with induration.] From DM Staff nāsu sutēshon kara insurin jiko chuusha bui shidou no juuyousei kouketsu no aru kanja heno shidouyou sīto no kufuu. Practice. 2001;18(2):202–3 (in Japanese). Yajima K. [Pitfalls of internal medicine medical therapy/endocrinology and metabolism/type 1 and type 2 diabetes mellitus/Do not omit checking the insulin technique in patients with long-term use of insulin injections.] Naika chiryou pittofōru naibunpi·taisha 1 gata/2 gata tounyoubyou insurin chusha chouki shiyou kanja demo shugi kakunin ha shouryaku shinai. Int Med. 2010;106(6):1214–5 (in Japanese). Baba A. Implications for nursing from a case whose glycemic control was improved by continual nursing. J Mitsubishi Kobe Hosp. 2012;2:41–6 (in Japanese). Yoshizaki T, Honda M. Insulin absorption in a patient with local subcutaneous amyloid deposition. J Japan Diabetes Soc. 2012;55(10):786–92 (in Japanese). Ozaki N, Hatakeyama N, Teratani T, Endo N, Nagahara S, Oshita N, et al. [A case of insulin-related subcutaneous induration identified by MRI in a patient with poor glycemic control.] Kettou kontorōru furyou no kanja ni MRI kensa nite insurin hika kouketsu wo kakunin sita 1 shourei. J Hokkaido Soc of Hosp Pharm. 2014;87:7–9 (in Japanese). Suzuki R, Yamato H, Kawazoe K, Aihara K, Endo I, Aki, N, et al. [Investigation of actual conditions and usefulness of the interventions in patients with insulin-related subcutaneous induration.] Insurin chusha ni yori shoujita hika kouketsu wo yuu suru kanja no jittai chousa to sono kainyu no yuuyousei no kentou. Practice. 2014;31(6):815–21 (in Japanese). Yamashiro K, Takahashi C, Kamimura S, Iida N, Yokota A, Inagaki H, et al. The importance of subcutaneous mass detection in insulin injection sites and the guidance of site rotation. J Japan Diabetes Soc. 2015;58(7):439–45 (in Japanese). Kusuki K, Yoshizaki T, Takeda T, Honda M. The analysis of histology, imaging findings, and insulin absorption about subcutaneous masses which occurred in insulin injection sites. J Japan Diabetes Soc. 2015;58(6):388–97 (in Japanese). Yabe S, Takahashi H, Gotoda H, Mori T, Ikawa H, Kudo H, et al. A case of type 1 diabetes mellitus with marked poor glycemic control caused by insulin-derived amyloidosis at the site of repeated insulin injections. J Japan Diabetes Soc. 2015;58(1):34–40 (in Japanese). Ishii A, Takemoto M, Iida S, Kanatsuka A. (Abdominal induration caused by repeated same site insulin injections is related to the HbA1c level and diurnal fasting blood glucose variation in type 2 diabetics. J Japan Diabetes Soc. 2015;58(2):94–9 (in Japanese). Shiba M, Kitazawa T. Progressive insulin-derived amyloidosis in a patient with type 2 diabetes. Case Reports Plast Surg Hand Surg. 2016;3(1):73–6. https://doi.org/10.1080/23320885.2016.1247650. Hagiwara S, Taneda S, Fukumoto T, Hagiwara K, Kikuchi M, Kimura T, et al. Localized subcutaneous insulin-derived amyloidosis excised after evaluation using ultrasonography in a patient with type 2 diabetes mellitus. Case Rep Endocrinol. 2017. https://doi.org/10.1155/2017/3985214. Kikuchi M, Hirokawa N, Hagiwara S, Nakayama H, Taneda S, Manda N, et al. Ultrasonography improves glycemic control by detecting insulin-derived localized amyloidosis. Ultrasound Med Biol. 2017;43(10):2284–94. https://doi.org/10.1016/j.ultrasmedbio.2017.06.011. Higuchi T, Abe F, Mitsuyama S, Kimura M, Nagayama D. A case of insulin ball exhibiting reduction of size by the adequate guidance of insulin injection. Pract Dermatol. 2017;39(6):629–32 (in Japanese). Okamoto T, Oguma T. A case of insulin ball–amyloidoma associated with insulin injection site. J Japan Soc Plast and Reconstr Surg. 2018;37(11):644–7 (in Japanese). Utsunomiya R, Miyawaki S, Fujiyama M, Ohbayashi M, Sasayama K. [A case of insulin ball in a patient with type 1 diabetes mellitus.] 1 gata tounyoubyou kanja ni shoujita insurin bōru no 1 rei. Rinsho Derma. 2018;72(10):753–8 (in Japanese). Kanamaru Y, Ryomoto K, Nagatomo M, Miyashita K, Takahara M, Kubo F, et al. Influence of non-palpable subcutaneous tissue changes on the glycemic control in insulin-treated patients with diabetes. J Japan Diabetes Soc. 2018;61(3):117–25 (in Japanese). Tomita S, Yoshida Y, Muneuchi G. Minimally invasive surgery for insulin-derived amyloidosis (insulin ball) in consideration of physical appearance. J Japan Soc Plast Reconstr Surg. 2018;38(4):207–12 (in Japanese). Wakabayashi Y, Ryomoto K, Nagatomo M, Kanamaru Y, Nojiri S, Ohashi M. Changes in the glycemic control and abnormal sonographic appearance of the injection region after the alteration of injection sites in patients with diabetes. J Japan Diabetes Soc. 2019;62(10):659–66 (in Japanese). Yokota M, Ohtsuka, Y, Ohmuta S, Sakai M, Koshimizu M, Nagamura H, et al. [Poor glycemic control caused by insulin injection to the insulin ball in a patient with acute subdural hematoma.] Fukubu no insurin bōru ni insurin tyuusha wo shita koto de kettouchi no akka wo kitashita kyuusei koumakuka kesshu no 1 shourei. Brain Nursing, 2020;36(9):938–43 (in Japanese). Kikuchi Y, Sugimura K. [(Chapter 2) Insulin basics and usage/Beware insulin balls in patients with poor response to insulin.—Recommendation for the calendrical injection method.]. Dai 2 syou insurin no kihon to tsukaikata insurin chusha ga kika nai kanja insurin bōru ni chuui karendā shiki chuushahou no susume. Resident Note Extra Number. 2020;22(5):943–50 (in Japanese). Miyata R, Takenaka Y, Ishiguro N. [Drug eruption/drug disorders: a case of multiple insulin balls in the abdomen] Yakushin·yakubutsu shougai fukubu ni tahatsu shita insurinbōru no 1 rei. Rinsho Derma. 2020;62(3):299–302 (in Japanese). Nagase T, Iwaya K, Kogure K, Zako T, Misumi Y, Kikuchi M, et al. Insulin-derived amyloidosis without a palpable mass at the insulin injection site: a report of two cases. J Diabetes Investig. 2020;11(4):1002–5. https://doi.org/10.1111/jdi.13199. Togame N, Saeki C, Takahashi K, Igawa H, Moriya K, Terakawa M, et al. [Diabetes education card system in educational hospitalization: A case report.] Kyouiku nyuin de tounyoubyou ryouyou shidou kādo shisutemu wo shiyou shita ichi syourei. J Jyuzen General Hospital. 2020;26(1):21–3 (in Japanese). Kranc C, Wagner R, Joy NM, Feldman J, Reid DC. Cutaneous insulin-derived amyloidosis presenting as hyperkeratotic nodules. Cutis. 2021;107(1):E6–E9. https://doi.org/10.12788/cutis.0161. Uchimoto S. [A case of 8-year follow-up of insulin balls: Improving glycemic control by adequate guidance for insulin injection.] Insurin bōru ga hakken sare insurin chusha shugi shidou ni yori kettou kontorōru ga kaizenshi 8 nenkan insurin bōru no keika wo oeta 1 rei. J Pract Diabetes. 2022;39(1):102–5 (in Japanese). Nilsson M. Insulin amyloid at injection sites of patients with diabetes. Amyloid. 2016;23(3):139–47. https://doi.org/10.1080/13506129.2016.1179183. Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–55. https://doi.org/10.1016/j.mayocp.2016.06.010. Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Mayo Clin Proc. 2016;91(9):1224–30. https://doi.org/10.1016/j.mayocp.2016.06.012. Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 2005;28(8):2025–7. https://doi.org/10.2337/diacare.28.8.2025. Iwaya K, Zako T, Fukunaga J, Sörgjerd KM, Ogata K, Kogure K, et al. Toxicity of insulin-derived amyloidosis: a case report. BMC Endocr Disord. 2019;19(1):61. https://doi.org/10.1186/s12902-019-0385-0. Ansari AM, Osmani L, Matsangos AE, Li QK. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis. 2017;213(10):1237–41. https://doi.org/10.1016/j.prp.2017.08.013. Overland J, Molyneaux L, Tewari S, Fatouros R, Melville D, Foote D, et al. Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system. Diabetes Obes Metab. 2009;11(5):460–3. https://doi.org/10.1111/j.1463-1326.2008.00972.x.